← Back to Search

Artificial Disc

Kineflex-C for Degenerative Disc Disease

N/A
Waitlist Available
Led By Fred Geisler, MD
Research Sponsored by SpinalMotion
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to show that the Kineflex\|C Spinal System is no worse than conventional Anterior Cervical Diskectomy with Fusion (ACDF) in patients with single level degenerative disc disease at any cervical level from C3 to C7.

Eligible Conditions
  • Degenerative Disc Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Kineflex-CExperimental Treatment2 Interventions
Group II: ACDFActive Control2 Interventions

Find a Location

Who is running the clinical trial?

SpinalMotionLead Sponsor
1 Previous Clinical Trials
514 Total Patients Enrolled
Fred Geisler, MDPrincipal InvestigatorMedical Monitor
1 Previous Clinical Trials
514 Total Patients Enrolled
~17 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top